Selectivity of the collagen-binding integrin inhibitors, TC-I-15 and obtustatin.
Journal Information
Full Title: Toxicol Appl Pharmacol
Abbreviation: Toxicol Appl Pharmacol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declaration of Competing Interest RWF is Chief Scientific Officer, CambCol Laboratories, Ely, Cambs, UK."
Funding Disclosure
Evidence found in paper:
"This study was funded by grants from the 10.13039/501100000274British Heart Foundation: SP/15/7/31561 to RF; RG/15/4/31268 to RF, and FS/15/20/31335 to RF and EH."
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025